positive
Pharma & IT Stocks Lead Indian Market Gains on October 10

Indian equities advanced, led by strong gains in pharma and IT sectors, as foreign institutional investors turned net buyers amid easing geopolitical tensions. The Nifty Pharma index rose 1.8%, while Nifty IT gained 1.2%, driven by renewed optimism in export-oriented earnings. Analysts said improving global sentiment and stable rupee trends are boosting outlooks for defensive sectors. Broader market sentiment remained positive, with investors positioning for steady Q3 growth momentum.
Tags:
- Nifty Pharma
- Nifty IT
Thehindu• By Harsh Ranjan
Explore:High Return Equity Mutual Fund
positive
Pharma & IT Stocks Lead Indian Market Gains on October 10

Indian equities advanced, led by strong gains in pharma and IT sectors, as foreign institutional investors turned net buyers amid easing geopolitical tensions. The Nifty Pharma index rose 1.8%, while Nifty IT gained 1.2%, driven by renewed optimism in export-oriented earnings. Analysts said improving global sentiment and stable rupee trends are boosting outlooks for defensive sectors. Broader market sentiment remained positive, with investors positioning for steady Q3 growth momentum.
Tags:
- Nifty Pharma
- Nifty IT
Thehindu• By Harsh Ranjan
Explore:High Return Equity Mutual Fund
1 min read
69 words

Pharma and IT stocks led Indian market gains on renewed investor optimism.
Indian equities advanced, led by strong gains in pharma and IT sectors, as foreign institutional investors turned net buyers amid easing geopolitical tensions. The Nifty Pharma index rose 1.8%, while Nifty IT gained 1.2%, driven by renewed optimism in export-oriented earnings. Analysts said improving global sentiment and stable rupee trends are boosting outlooks for defensive sectors. Broader market sentiment remained positive, with investors positioning for steady Q3 growth momentum.

Indian equities advanced, led by strong gains in pharma and IT sectors, as foreign institutional investors turned net buyers amid easing geopolitical tensions. The Nifty Pharma index rose 1.8%, while Nifty IT gained 1.2%, driven by renewed optimism in export-oriented earnings. Analysts said improving global sentiment and stable rupee trends are boosting outlooks for defensive sectors. Broader market sentiment remained positive, with investors positioning for steady Q3 growth momentum.
Tags:
- Nifty Pharma
- Nifty IT
- Nifty Pharma
- Nifty IT
- foreign investors
- Indian markets
- Q3 outlook